A case of nonpigmented fixed‐drug eruption with eosinophilic intraepidermal vesicle formation

The Journal of DermatologyEarly View LETTER TO THE EDITOR A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation Keiko Sakamoto, Corresponding Author Keiko Sakamoto [email protected] orcid.org/0000-0001-8957-3232 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan Cutaneous Leukocyte Biology Section, Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA Correspondence Keiko Sakamoto, Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan. Email: [email protected]Search for more papers by this authorMayu Fujihiro, Mayu Fujihiro Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorAtsushi Sakamoto, Atsushi Sakamoto orcid.org/0000-0002-6372-9224 Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorChika Yamada, Chika Yamada Yamada hihuka, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorKeisuke Nagao, Keisuke Nagao orcid.org/0000-0002-7005-3138 Cutaneous Leukocyte Biology Section, Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USASearch for more papers by this authorTetsuya Honda, Tetsuya Honda orcid.org/0000-0003-2355-4869 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this author Keiko Sakamoto, Corresponding Author Keiko Sakamoto [email protected] orcid.org/0000-0001-8957-3232 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan Cutaneous Leukocyte Biology Section, Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA Correspondence Keiko Sakamoto, Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan. Email: [email protected]Search for more papers by this authorMayu Fujihiro, Mayu Fujihiro Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorAtsushi Sakamoto, Atsushi Sakamoto orcid.org/0000-0002-6372-9224 Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorChika Yamada, Chika Yamada Yamada hihuka, Hamamatsu, Shizuoka, JapanSearch for more papers by this authorKeisuke Nagao, Keisuke Nagao orcid.org/0000-0002-7005-3138 Cutaneous Leukocyte Biology Section, Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USASearch for more papers by this authorTetsuya Honda, Tetsuya Honda orcid.org/0000-0003-2355-4869 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSearch for more papers by this author First published: 10 November 2023 https://doi.org/10.1111/1346-8138.17022Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Anderson HJ, Lee JB. A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina. 2021; 57: 925. 10.3390/medicina57090925 PubMedWeb of Science®Google Scholar 2Patel S, John AM, Handler MZ, Schwartz RA. Fixed drug eruptions: an update, emphasizing the potentially lethal generalized bullous fixed drug eruption. Am J Clin Dermatol. 2020; 21: 393–399. 10.1007/s40257-020-00505-3 PubMedWeb of Science®Google Scholar 3Mizukawa Y, Yamazaki Y, Shiohara T. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol. 2008; 158: 1230–1238. 10.1111/j.1365-2133.2008.08516.x CASPubMedWeb of Science®Google Scholar 4Li A, Kazlouskaya V. Neutrophils in fixed drug eruptions: correction of a mistaken hypothesis. Am J Dermatopathol. 2022; 44: 106–110. 10.1097/DAD.0000000000002038 PubMedWeb of Science®Google Scholar 5Fettrelet T, Gigon L, Karaulov A, Yousefi S, Simon HU. The enigma of eosinophil degranulation. Int J Mol Sci. 2021; 22: 7091. 10.3390/ijms22137091 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation